4//SEC Filing
Russell Kerry Strong 4
Accession 0001562180-22-005608
CIK 0001831363other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 8:07 PM ET
Size
5.7 KB
Accession
0001562180-22-005608
Insider Transaction Report
Form 4
Russell Kerry Strong
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-07-01+240,000→ 240,000 totalExercise: $2.69Exp: 2032-06-30→ Common Stock (240,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on the first anniversary measured from May 31, 2022 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.
Documents
Issuer
Terns Pharmaceuticals, Inc.
CIK 0001831363
Entity typeother
Related Parties
1- filerCIK 0001927137
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 8:07 PM ET
- Size
- 5.7 KB